bims-pideca Biomed News
on Class IA PI3K signalling in development and cancer
Issue of 2026–05–24
27 papers selected by
Ralitsa Radostinova Madsen, MRC-PPU



  1. Acta Neuropathol. 2026 May 20. pii: 60. [Epub ahead of print]151(1):
      Tuberous sclerosis complex (TSC) is a rare disease caused by mutations in TSC1 and TSC2, resulting in activation of mechanistic target of rapamycin complex 1 (mTORC1). Neurological manifestations in TSC patients include epilepsy, autism and intellectual disability. Two types of brain lesions, cortical tubers and subependymal giant cell astrocytomas (SEGAs), cause the majority of neurological manifestations in TSC. We have limited understanding of the molecular changes that occur in tubers and SEGAs and how these contribute to disease pathogenesis. To investigate this, we performed proteomic and phosphoproteomic analysis of TSC patient tuber and SEGA tissue. Tubers showed evidence of alterations in mitochondrial respiration, cytoskeleton organisation and neuronal function. However, we were unable to detect mTORC1 activation in tubers, likely due to the small number of cells with complete inactivation of TSC1 or TSC2. By contrast, SEGAs showed evidence of strong mTORC1 activation and large-scale changes in the proteome and phosphoproteome. SEGAs exhibited increased expression of ribosomal proteins and activation of a neuroinflammatory response. Phosphoproteomics identified 6060 phosphosites within 2154 proteins increased in SEGAs. Phosphorylation of multiple proteins involved in RNA-metabolism, including mRNA splicing, was increased in SEGAs. Consistent with this, we found evidence of extensive alterations in mRNA transcript splicing in SEGA tissue that is shared with a wide range of cancers. These data greatly expand the repertoire of known mTORC1 target proteins in the human brain and reveal that large-scale mis-regulation of mRNA splicing may promote the formation of SEGAs in TSC.
    Keywords:  Phosphoproteomics; SEGA; Signalling; TSC; Tuber; mTOR
    DOI:  https://doi.org/10.1007/s00401-026-03022-5
  2. J Immunol. 2026 May 14. pii: vkag002. [Epub ahead of print]215(5):
      Phosphoinositide 3-kinase (PI3K) mediates signaling downstream of many receptors expressed by B cells. Studies in both mice and humans have shown that PI3K plays a critical role in B-cell development, activation, and tolerance. Indeed the key role of PI3K in regulating activation versus tolerance is demonstrated by patients with genetic variants that cause increased PI3K signaling, which results in an immune dysregulatory disorder characterized by a range of manifestations including lymphoproliferation and autoantibody production. Interestingly, PI3K signaling also plays an essential role in metabolic reprogramming. This review examines the role of PI3K signaling in regulating both central and peripheral B-cell tolerance and how dysregulation of these pathways can lead to production of autoantibodies. It also briefly explores PI3K-mediated changes in metabolism and considers how this may contribute to PI3K-mediated control of B-cell activation and tolerance.
    Keywords:  B cells; PI3K; autoimmunity; tolerance
    DOI:  https://doi.org/10.1093/jimmun/vkag002
  3. Cell Chem Biol. 2026 May 21. pii: S2451-9456(26)00140-6. [Epub ahead of print]33(5): 583-585
      In this issue of Cell Chemical Biology, Park et al.1 identify 13-S-HODE, a metabolite derived from the dietary lipid linoleic acid, to be an ATP-competitive inhibitor of mTOR. 13-S-HODE inhibition of mTORC1 and mTORC2 signaling offers a new mechanistic explanation for the tumor-suppressive activity of this lipid metabolite.
    DOI:  https://doi.org/10.1016/j.chembiol.2026.04.005
  4. J Immunol. 2026 May 14. pii: vkag075. [Epub ahead of print]215(5):
      Among the PI3K isoforms, PI3Kδ has attracted particular attention from immunologists and hematologists. Despite earlier clinical setbacks, the PI3Kδ field has recently re-emerged with renewed promise. Here, I highlight key milestones in the evolving understanding of PI3Kδ signaling in immunity and cancer, and pivotal studies that have shaped this field.
    Keywords:  PI3K, PI 3-kinase, signaling, cancer, leukemia, lymphoma, drug, medicine
    DOI:  https://doi.org/10.1093/jimmun/vkag075
  5. Biochem Soc Trans. 2026 May 27. 54(5): 585-599
      During each cell cycle, cells must decide whether to continue to proliferate or to exit the cell cycle into a reversible arrest state, known as quiescence, or G0. This decision must be highly regulated to ensure proper tissue homeostasis. Studies on kinase-driven signalling pathways that regulate this decision point have dominated the field, and the role of phosphatases remains comparatively underexplored, yet the role of phosphatases is vitally important in signal transduction. In the present review, we examine how phosphatases contribute to the regulation of quiescence in mammalian cells across three stages: entry into quiescence, maintenance of the quiescent state, and quiescence exit into the cell cycle. We discuss how phosphatases counteract mitogenic signalling pathways, including MAPK/ERK and PI3K-AKT-mTOR, and maintain low cyclin-dependent kinase (CDK) activity through dephosphorylation of key cell cycle regulators, such as the retinoblastoma family proteins and CDK inhibitors. Finally, we highlight emerging evidence that dynamic regulation of phosphatase activity shapes the transition from quiescence back into proliferation. Understanding how phosphatases regulate the reversible nature of cell cycle arrest is important for understanding how tissues maintain homeostasis and how dysregulation of quiescence contributes to disease, including cancer.
    Keywords:  cell cycle; cell proliferation; protein phosphatases; quiescence; signalling
    DOI:  https://doi.org/10.1042/BST20250091
  6. Port J Card Thorac Vasc Surg. 2026 May 10. 33(1): 33-39
       BACKGROUND: Sirolimus, an mTOR inhibitor, has transformed the management of complex slow- flow vascular malformations (VAMs), particularly those driven by PI3K/AKT/mTOR pathway activation. Evidence from prospective trials and real- world cohorts supports its use in venous, lymphatic and combined malformations, as well as in PIK3CA- related overgrowth spectrum (PROS) and PTEN hamartoma tumor syndrome (PHTS). However, sirolimus shows poor or absent benefit in fast- flow lesions such as arteriovenous malformations (AVMs).
    METHODS: This narrative review of the recent literature (2020- 2025) was performed using PubMed, focusing on molecular mechanisms, clinical efficacy, safety, quality of life, therapeutic drug monitoring (TDM) and cost- utility of sirolimus in vascular anomalies.
    RESULTS: Sirolimus demonstrates high response rates in slow- flow malformations, with partial responses in approximately 60-85%60-85% of patients and clinically meaningful improvements in health- related quality of life (HRQoL). Lower trough levels (4- 10 ng/mL) provide comparable efficacy with reduced toxicity. Adverse effects include oral mucositis, dyslipidemia, fatigue and infections. In contrast, fast- flow malformations show negligible benefit, consistent with their distinct genetic architecture, which predominantly activates RAS/MAPK rather than PI3K/AKT/mTOR signalling.
    CONCLUSIONS: Sirolimus is an effective targeted therapy for refractory slow- flow vascular malformations but should not be considered a universal treatment for all vascular anomalies. Future directions include molecularly guided therapy, rational combination regimens and integration with PI3K- and AKT- directed agents.
    Keywords:  imunosupressive agents/adverse effects; quality of life; sirolimus; vascular anomalies; vascular malformations
    DOI:  https://doi.org/10.48729/pjctvs.614
  7. bioRxiv. 2026 May 07. pii: 2026.05.04.722723. [Epub ahead of print]
      The vascular system exhibits complex, non-planar geometries that become further distorted during pathological remodeling, including arterial tortuosity and aneurysms. Although hemodynamic shear stress is a well-established regulator of vascular function, the direct effects of curvature as an intrinsic geometric cue remain poorly defined. This is largely because existing in vitro models are static and fail to capture the dynamic changes that accompany disease progression. To address this gap, we used a magnetoactive hydrogel platform that enables real-time, on-demand curvature of endothelial monolayers to reproduce clinically established tortuosity metrics. Using this system, we found that elevated curvature increased nuclear localization of yes-associated protein (YAP), with the strongest response in convex relative to concave regions of highly tortuous endothelial monolayers. This mechanosensitive response was accompanied by reduced VE-Cadherin junctional thickness and increased membrane localization of endothelial nitric oxide synthase. Together, these findings identify local curvature, independent of shear stress, as a regulator of endothelial cell mechanosensing and function, and establish a dynamic hydrogel platform for isolating geometric regulation from shear stress inputs in vascular mechanobiology.
    DOI:  https://doi.org/10.64898/2026.05.04.722723
  8. Annu Rev Nutr. 2026 May 21.
      Preterm birth disrupts nutrient-responsive signaling pathways critical for skeletal muscle growth and long-term metabolic health. Despite improvements in neonatal care, preterm infants often experience postnatal growth failure marked by impaired lean mass accretion. This review examines how prematurity intrinsically alters insulin and amino acid signaling to mechanistic target of rapamycin complex 1 (mTORC1), a central regulator of translation initiation and protein synthesis. Evidence from translational models reveals blunted activation of mTORC1 and its downstream effectors, independent of birth weight or comorbidities. Defects in insulin-PDK1/mTORC2-Akt signaling and amino acid sensing, particularly leucine sensing, contribute to impaired mTORC1-dependent translation initiation and reduced muscle protein synthesis. Feeding strategies that mimic physiological nutrient pulsatility, including intermittent bolus feeding and pulsatile leucine supplementation during continuous feeding, show promise in restoring anabolic signaling. Understanding these molecular impairments provides a foundation for targeted nutritional and therapeutic interventions to improve muscle growth and mitigate long-term health risks in individuals born preterm.
    DOI:  https://doi.org/10.1146/annurev-nutr-111225-024640
  9. Nat Commun. 2026 May 21.
      Impaired suppression of endogenous glucose production (EGP) drives end-organ damage in insulin resistance and type 2 diabetes. Although the liver is traditionally thought to mediate dysregulated EGP, the role of the renal cortex is less understood. Here, we investigate if high-fat diet (HFD) induces renal cortical insulin resistance while assessing renal glucose production (RGP) and mitochondrial metabolism in male mice. HFD increases plasma membrane sn-1,2-DAGs, PKCε translocation, and Insulin Receptor Kinase (IRK)T1160 phosphorylation while blunting insulin-stimulated pyruvate oxidation and insulin signaling. In HFD mice, RGP is elevated 6.5-fold and accounts for 60% of EGP during hyperinsulinemia. Excess RGP is derived equally from glycerol and mitochondrial sources, chiefly pyruvate. Signaling and flux defects are abrogated in HFD-fed IRKT1150A knockin mice, except for glycerol-derived gluconeogenesis. Our findings implicate the sn-1,2-DAG → PKCε → IRKT1160 axis in renal cortical insulin resistance and highlight renal gluconeogenesis as a driver of dysregulated glucose homeostasis.
    DOI:  https://doi.org/10.1038/s41467-026-73016-0
  10. Cell Rep Methods. 2026 May 21. pii: S2667-2375(26)00159-1. [Epub ahead of print] 101459
      Predicting coordinated cellular responses to perturbations is crucial for phenotypic drug discovery and building virtual cell models. Current methods typically predict isolated modalities or require empirical post-perturbation data, precluding true de novo virtual screening. To address this, we introduce MultiVCDiff, a unified multimodal generative diffusion framework that simultaneously predicts high-fidelity cellular morphology images and transcriptomic profiles directly from chemical or genetic perturbations. This framework was trained on a comprehensive trimodal corpus encompassing 1,118 chemical and 130 genetic perturbations across four datasets. Evaluated under strict zero-shot settings on unseen drugs, MultiVCDiff outperforms state-of-the-art single-modality baselines. It successfully overcomes morphological mode collapse, generates highly accurate gene expression signatures, and captures complex biological relationships to reliably retrieve drug mechanisms of action. By eliminating the dependency on prior post-perturbation readouts, MultiVCDiff enables scalable in silico hypothesis generation, significantly accelerating drug discovery and advancing holistic virtual cell modeling.
    Keywords:  CP: computational biology; CP: systems biology; Cell Painting; L1000; cellular morphology synthesis; diffusion model; gene expression prediction; in silico phenotypic screening; multimodal generative model; perturbation response prediction; virtual cell modeling; virtual screening
    DOI:  https://doi.org/10.1016/j.crmeth.2026.101459
  11. bioRxiv. 2026 May 08. pii: 2026.05.05.723030. [Epub ahead of print]
    Cellanome Development Team
      Dynamic transitions between cell states underlie both normal physiology and disease. However, most single-cell technologies capture only static snapshots. To address this gap, we developed a platform that integrates light-guided hydrogel polymerization with computer vision to generate on-demand compartments around live cells, enabling longitudinal imaging of cellular behavior paired with whole-transcriptome profiling of the same cells at scale. These data link dynamic phenotypes with molecular programs, enabling deeper characterization of cellular states. This approach revealed an adaptive, drug-resistant state in lung cancer cells characterized by potassium channel upregulation and p53-dependent quiescence. In models of adipogenesis and microglial phagocytosis, joint analysis of imaging and transcriptomic data identified key drivers of cellular function that were missed by transcriptomic clustering alone. These results establish the value of paired functional and transcriptomic analysis to resolve molecular drivers of complex cellular behaviors.
    DOI:  https://doi.org/10.64898/2026.05.05.723030
  12. Nat Commun. 2026 May 22.
      Neurovascular unit (NVU) communications guide vascular patterning, BBB maturation, and neuronal homeostasis, yet whether these interactions differ across brain regions and how they regulate the vasculature during development remains unclear. Here, we combine spatial transcriptomics with region-resolved endothelial single-cell RNA sequencing in the postnatal mouse brain to map cortical and thalamic NVU communication dynamics. We uncover spatiotemporal divergence of endothelial programs and show that neuronal and glial maturation parallels region-specific angiogenic trajectories. We identify neuronal-endothelial TGFβ2 signaling as an essential regulator of thalamic vascularization during a defined postnatal developmental window. Loss of endothelial TGFβR1 signaling leads to mTOR hyperactivation and thalamus-predominant vascular malformations and hemorrhage within this developmental window, and these defects are rescued by mTOR inhibition. Together, these findings show that circuit maturation and region-specific NVU communication programs coordinate postnatal angiogenesis and vascular maturation, providing a framework for understanding regional vulnerability in neurovascular disorders.
    DOI:  https://doi.org/10.1038/s41467-026-73373-w
  13. Sci Signal. 2026 May 19. 19(938): eaed1622
      Receptor tyrosine kinase (RTK) signaling drives cancer and is a validated therapeutic target. Modulators of RTK signaling can reveal mechanisms of oncogenesis and offer new therapeutic targets. Golgi phosphoprotein 3 (GOLPH3) is a Golgi-localized oncoprotein that promotes signaling downstream of mTOR. Here, examination of RTK signaling indicated that GOLPH3 acted at the level of the RTK and increased all downstream signaling. We found that GOLPH3 enhanced the delivery of RTKs to the plasma membrane. This role was shared with its binding partner myosin 18A (MYO18A) and depended on the interaction of GOLPH3 with MYO18A. The GOLPH3-MYO18A complex at the Golgi apparatus was required and rate-limiting for RTK signaling across the cell types and receptors assessed. Our findings provide insight into the relationship between the function of GOLPH3 at the Golgi and its role as a cancer driver, highlighting its potential as a therapeutic target in cancer.
    DOI:  https://doi.org/10.1126/scisignal.aed1622
  14. bioRxiv. 2026 May 07. pii: 2026.05.04.722722. [Epub ahead of print]
      Computational protein engineering provides a powerful approach to address longstanding clinical challenges. Severe insulin resistance syndromes caused by mutations in the insulin receptor (IR) are life-threatening disorders for which effective long-term therapies remain lacking. Here, we define the in vivo activity and therapeutic potential of RF-409, a de novo-designed IR agonist that activates the receptor through a mechanism distinct from insulin. RF-409 exhibits markedly prolonged circulation compared to insulin and produces sustained improvements in glucose homeostasis without detectable adverse effects on body composition or liver function. In a patient-derived IR D707A mouse model of severe insulin resistance, RF-409-but not insulin-activates the mutant receptor, restoring glucose regulation and ameliorating hyperglycemia, hyperinsulinemia, lipoatrophy, and pancreatic atrophy. Mechanistically, RF-409 engages the IR through a noncanonical binding geometry while stabilizing an active conformation resembling that induced by insulin. Phosphoproteomic profiling shows that RF-409 elicits broadly insulin-like signaling with distinct temporal features in receptor-proximal regulation. Together, these findings establish a framework for reactivating dysfunctional receptors and suggest broader applications beyond rare receptoropathies, including diabetes and liver disease.
    DOI:  https://doi.org/10.64898/2026.05.04.722722
  15. Proc Natl Acad Sci U S A. 2026 May 26. 123(21): e2527896123
    IMAXT Cancer Grand Challenge Consortium
      Mapping the molecular identities and functions of cells within their spatial context is key to understanding the complex interplay within and between tissue neighborhoods. A wide range of methods have recently enabled spatial profiling of cellular anatomical contexts, some offering single-cell resolution. These use different barcoding schemes to encode either the location or the identity of target molecules. However, all these technologies face a trade-off between spatial resolution, depth of profiling, and scalability. Here, we present Barcoding by Activated Linkage of Indexes (BALI), a method that uses light to write combinatorial spatial molecular barcodes directly onto target molecules in situ, enabling multiomic profiling by next generation sequencing. A unique feature of BALI is that the user can define the number, size, shape, and resolution of the spatial locations to be interrogated, with the potential to profile millions of distinct regions with subcellular precision. As a proof of concept, we used BALI to capture the transcriptome, chromatin accessibility, or both simultaneously, from distinct areas of the mouse brain in single tissue sections, demonstrating strong concordance with publicly available datasets. We also developed an integrated instrument that automates combinatorial barcode writing on tissue sections, enabling high-throughput profiling. BALI therefore combines high spatial resolution, high throughput, compatibility with standard histological pipelines, and workflow accessibility to enable tunable spatial multi-omic profiling.
    Keywords:  RNA expression; chromatin accessibility; spatial profiling
    DOI:  https://doi.org/10.1073/pnas.2527896123
  16. bioRxiv. 2026 May 07. pii: 2026.05.05.722960. [Epub ahead of print]
      Fluorescent biosensors that report protein conformation in vivo have been invaluable for understanding how the spatio-temporal dynamics of signaling controls cells. However, for GTPases these biosensors report the activated conformation using reagents that block the binding of downstream proteins, generating dominant negative effects and altering normal cell physiology. We present here a generalizable design to make GTPase biosensors (AlloRac1 and AlloCdc42), in which a circularly permuted fluorescent protein is inserted into a conserved loop allosterically connected to the effector binding site, generating activity-dependent fluorescence without blocking ligand interactions. The Rac1 biosensor showed that effector interactions led to increased Rac1 activation, indicating an auto-regulatory positive feedback made visible by the new biosensor design. This feedback regulated the kinetics and localization of Rac1 activity, including Rac1 activity gradients that controlled motility. Feedback was generated through Rac1 interaction with the effector Pak1, which led to further activation of Rac1 by the guanine exchange factor β-Pix. The new biosensor approach enables quantitative imaging of previously obscure spatio-temporal dynamics in GTPase regulation.
    DOI:  https://doi.org/10.64898/2026.05.05.722960
  17. Sci Adv. 2026 May 22. 12(21): eaeb8658
      In p53-deficient cancers, targeting cholesterol metabolism has emerged as a promising therapeutic approach, given that p53 loss dysregulates sterol regulatory element-binding protein 2 pathways, thereby enhancing cholesterol biosynthesis. While cholesterol synthesis inhibitors such as statins have shown initial success, their efficacy is often compromised by the development of acquired resistance. Consequently, strategies are being explored to disrupt cholesterol homeostasis more comprehensively by inhibiting its synthesis and intracellular transport. In this study, we investigate a previously underexplored function of PI5P4Ks, which catalyzes the conversion of PI(5)P to PI(4,5)P2 at intracellular membranes. Our findings reveal that PI5P4Ks play a key role in facilitating lysosomal cholesterol transport, regulating lysosome positioning, and sustaining growth signaling via the mechanistic target of rapamycin (mTOR) pathway. While PI5P4Ks have previously been implicated in mTOR signaling and tumor proliferation in p53-deficient contexts, this work elucidates an upstream mechanism that unifies these earlier observations.
    DOI:  https://doi.org/10.1126/sciadv.aeb8658
  18. Dev Cell. 2026 May 19. pii: S1534-5807(26)00159-0. [Epub ahead of print]
      The lack of accurate human models that recapitulate pancreatic ductal adenocarcinoma (PDAC) initiation has hindered therapeutic development. Using pluripotent stem cell-derived pancreatic progenitor organoids, we established a human PDAC model that faithfully reproduces the genetic, epigenetic, and transcriptomic trajectories of tumor initiation and progression, validated against clinical datasets and tumor histopathology. We demonstrate that CDKN2A loss, which is nearly universal in patients but dispensable in mouse models, is essential for neoplastic transformation when combined with KRAS and TP53 mutations, whereas SMAD4 loss promotes tumor progression. Multi-omics profiling reveals epigenetic repression of the pancreatic lineage program during PDAC initiation, alongside AP-1-driven chromatin remodeling. We identify TET1 suppression as a mechanistic link between oncogenic ERK signaling and hypermethylation of essential pancreatic transcription factors. This model captures genetic and epigenetic determinants of human PDAC, reveals antagonism between oncogenic and lineage restriction programs, and supports TET-based lineage restoration as a potential early intervention strategy.
    Keywords:  DNA methylation; TET1 suppression; activator protein-1; chromatin remodeling; gene editing; lineage plasticity; oncogenic KRAS; pancreatic ductal adenocarcinoma; pancreatic progenitor organoid; tumor suppressor gene
    DOI:  https://doi.org/10.1016/j.devcel.2026.04.012
  19. Cell Death Dis. 2026 May 19.
      Lung adenocarcinoma (LUAD) is the major histological subtype of non-small cell lung cancer (NSCLC). The mechanistic target of rapamycin complex 1 (mTORC1), a master regulator of anabolic growth and metabolism, has been implicated in unfavorable prognosis and therapeutic resistance in LUAD. Nevertheless, how this association is mechanistically established remains insufficiently understood. Here, by integrating TCGA/GEO datasets with our institutional LUAD single-cell RNA-seq, we identified the atypical E2F factor E2F8 as the member most closely associated with the mTORC1 pathway and found that E2F8 is upregulated in LUAD and that higher E2F8 levels correlate with adverse clinicopathological features and poorer prognosis. In PC-9 and H1975 cells, E2F8 overexpression enhanced proliferation, clonogenicity, migration, and xenograft growth, whereas E2F8 silencing produced the opposite effects; rapamycin partially reversed these phenotypes, indicating mTORC1 dependence. Mechanistically, E2F8 activated transcription of the HECT-type E3 ligase WWP1, which recognized PPxY-containing TSC1 and mediated K48-linked polyubiquitination at K662, promoting proteasomal degradation of TSC1 and sustaining mTORC1 signaling, as evidenced by increased p-mTOR (Ser2448), p-S6K1, and p-4EBP1. WWP1 knockdown markedly blunted E2F8-induced mTORC1 activation, preserved TSC1 abundance, and attenuated downstream mTORC1 readouts under E2F8/WWP1 activation, supporting TSC1 as the critical substrate. Pharmacologic WWP1 inhibition with indole-3-carbinol (I3C) restored TSC1, reduced p-mTOR (Ser2448), and suppressed LUAD xenograft growth, defining an E2F8-WWP1-TSC1-mTORC1 axis as a targetable circuit in LUAD.
    DOI:  https://doi.org/10.1038/s41419-026-08863-2
  20. J Cell Sci. 2026 May 21. pii: jcs.265025. [Epub ahead of print]
      Phosphatidylinositol (4,5)-bisphosphate (PIP2), the most abundant cellular poly-phosphoinositide (PPI) class of phospholipid, is a central plasma membrane (PM)-associated signaling hub that controls many cellular processes. In this study, we demonstrate that either deletion of the gene encoding actin-binding protein profilin1 (Pfn1) or disruption of Pfn1-actin interaction leads to downregulation of PM PIP2 content in cells. This is also phenocopied when F-actin is depolymerized implying that Pfn1-dependent PIP2 alteration is related to its actin-regulatory function. Phospholipase C (PLC) activity is critical for Pfn1-deficient cells to exhibit the PIP2-related phenotype. These findings, taken together with biochemical signatures of elevated PIP2 hydrolysis (higher baseline PM diacylglycerol-to PIP2 ratio and protein kinase C activity) exhibited by Pfn1-deficient cells, imply that PLC-mediated PIP2 hydrolysis plays a role in Pfn1-dependent regulation of PM PIP2. Furthermore, we unexpectedly found that Pfn1 loss leads to dramatic alterations in several other important forms of lipids, revealing a previously unrecognized role of Pfn1 as a broad regulator of cellular lipid environment that extends beyond PPI control. In conclusion, our study establishes Pfn1 as an important regulator of cellular lipid homeostasis.
    Keywords:  Actin; Diacylglycerol; Hydrolysis; PIP2; Phospholipase; Profilin1
    DOI:  https://doi.org/10.1242/jcs.265025
  21. Cancer Cell. 2026 May 21. pii: S1535-6108(26)00220-5. [Epub ahead of print]
      KRAS is mutationally activated in 45%-50% of colorectal cancer (CRC) cases, and while KRAS-targeted therapies have shown clinical promise, drug resistance limits their efficacy. To explore the mechanisms underlying KRAS inhibitor resistance, we use targeted exome sequencing and spatial transcriptomics on patient-matched CRC biopsies following combined treatment with KRASG12C and EGFR inhibitors. We show that acquired genetic events are identified in most patients at progression but are often subclonal and coexist with transcriptional adaptive states. Mesenchymal, YAP, and fetal-like transcriptional signatures predominate in resistant tumors, while inflammatory programs are induced early on treatment. Single-cell spatial analysis reveals intratumoral heterogeneity, with diverse adaptive states in different zones of individual tumors. Using human and murine organoid models, we show that drug-induced inflammatory programs are, at least in part, cancer-cell autonomous, and precede the emergence of drug resistance. We identify TBK1 as a target to abrogate the inflammatory adaptive phase and enhance responses to KRAS inhibition.
    Keywords:  CRC; KRAS; TBK1; inflammation; plasticity
    DOI:  https://doi.org/10.1016/j.ccell.2026.04.009
  22. Elife. 2026 May 22. pii: RP107154. [Epub ahead of print]14
      Whole-mount 3D imaging at the cellular scale is a powerful tool for exploring complex processes during morphogenesis. In organoids, it allows examining tissue architecture, cell types, and morphology simultaneously in 3D models. However, cell packing in multilayered organoid tissues hinders both deep imaging and quantification of cell-scale processes. To address these challenges, we developed an experimental and computational pipeline to extract properties at scales ranging from cell to tissue. The experimental module is based on two-photon imaging of immunostained organoids. The computational module corrects for optical artifacts, performs accurate 3D nuclei segmentation and reliably quantifies gene expression. We provide the computational module as a user-friendly Python package called Tapenade, along with napari plugins which enable joint data processing and exploration across scales. We demonstrate the pipeline by quantifying 3D spatial patterns of gene expression and nuclear morphology in gastruloids, revealing how local cell deformations and gene co-expression relate to tissue-scale organization. This quantitative pipeline improves our understanding of gastruloid development, and lays the groundwork for a wide range of multi-layered organoids and tumoroids systems.
    Keywords:  3D nuclei segmentation; computational biology; developmental biology; gastruloids; gene expression analysis; morphometrics; mouse; napari; systems biology; whole-mount 3D imaging
    DOI:  https://doi.org/10.7554/eLife.107154
  23. STAR Protoc. 2026 May 18. pii: S2666-1667(26)00205-4. [Epub ahead of print]7(2): 104552
      Techniques for differentiating human induced pluripotent stem cells (hiPSCs) into cardiomyocytes (hiPSC-CMs) can yield up to 98% purity, yet control over hiPSC-CM fate is lacking. Here, we present a protocol for insulin dosing during the expansion and maturation of hiPSC-derived cardiomyocytes. We describe steps for differentiation, purification, replating, cryopreservation, and thawing. We then detail a procedure for expansion using insulin and Wnt/β-catenin signaling, followed by steps to initiate maturation by either removing insulin completely or adding a low dose of insulin. For complete details on the use and execution of this protocol, please refer to Yuan et al.1.
    Keywords:  Cell Differentiation; Cell culture; Stem Cells
    DOI:  https://doi.org/10.1016/j.xpro.2026.104552
  24. Nat Rev Genet. 2026 May 18.
      Understanding how cells commit to distinct fates over time is fundamental to elucidating the principles and mechanisms that govern organismal development, tissue regeneration and disease progression. Multimodal lineage tracing, which couples heritable lineage information with single-cell multi-omics, has revolutionized our ability to chart cellular dynamics and fate decisions at unprecedented resolution. However, the resulting datasets are inherently complex and heterogeneous, calling for sophisticated computational frameworks capable of transforming raw measurements into coherent biological insights. Here we comprehensively survey recent methodological advances that substantially expand the computational toolkit for analysing lineage-resolved, single-cell multi-omic data, enabling more accurate lineage reconstruction, trajectory inference, ancestral state estimation and identification of molecular programmes driving cell-state transitions. Emerging high-resolution lineage-tracing technologies and deep learning-based analytical models promise to further unlock the full potential of multimodal lineage tracing, offering an increasingly complete and quantitative view of cellular evolution in both health and disease.
    DOI:  https://doi.org/10.1038/s41576-026-00969-9
  25. Stem Cell Reports. 2026 May 21. pii: S2213-6711(26)00139-6. [Epub ahead of print] 102928
    NYSCF Global Stem Cell Array Team
      Induced pluripotent stem cells (iPSCs) enabled the generation of diverse cell types; however, certain fundamental biological properties, such as the genetic and epigenetic determinants of proliferation, remain poorly characterized. We quantified proliferation across 602 unique donors with a time-lapse imaging-based growth area under the curve (gAUC) phenotype and correlated gAUC with cell line gene expression and genotype. We identified 3,091 differentially expressed genes and found that rare deleterious variants in WDR54, TMEM250, and C2orf81 were associated with reduced iPSC growth. Notably, WDR54 was differentially expressed with respect to gAUC. Although no common variants were associated, common genetic variation explained 71%-75% of the variance. These results indicate a complex genetic architecture of iPSC growth rates, where rare, large-effect variants in important growth regulators are layered onto a highly polygenic background. These findings can impact the design of pooled iPSC-based studies and disease models, which may be confounded by intrinsic growth differences.
    Keywords:  cell growth; genomic analysis; iPSC; stem cell
    DOI:  https://doi.org/10.1016/j.stemcr.2026.102928
  26. Clin Transl Sci. 2026 Jun;19(6): e70575
      In academia, the curriculum vitae (CV) is the central document used for hiring, promotion, or tenure applications. The content and format of these CVs and accompanying documents varies among institutions and is a direct reflection of the institution's values. Few institutions consider rigor, reproducibility, or transparency practices for hiring, promotion, or tenure decisions. We developed a new CV template for Stanford's School of Medicine for researchers to highlight their use of those practices, making it possible to evaluate faculty not just on research reports, but how they do the research itself. The new additions include listing (and linking) availability of protocols, analysis plans, analytic code, data, public accessibility of results for research outputs; registration number and result reporting for clinical trials; details of peer review activities; and candidate's persistent identifier (e.g., ORCID iD). We also include a variety of practices supporting research rigor and reproducibility that can be described in a candidate's narrative statement. For those who dedicate time and resources to maximize the rigor, reproducibility, and transparency of their work, our new CV template makes these efforts visible, a precondition for valuing them. This can serve as a model for other institutions, while future advances in scholarly metadata and systems could facilitate easier collection and reporting.
    DOI:  https://doi.org/10.1111/cts.70575